Meeting
2020 Genitourinary Cancers Symposium
18-year prostate cancer-specific mortality after prostatectomy, brachytherapy, external beam radiation therapy, hormonal therapy, or monitoring for localized prostate cancer.
Authors
Annika Herlemann
Dept. of Urology, University of California San Francisco, San Francisco, CA
Annika Herlemann , Janet E. Cowan , Samuel L. Washington III, Anthony C. Wong , Jenny M. Broering , Peter R. Carroll , Matthew R. Cooperberg
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 300)
Abstract #
300
Poster Bd #
L6
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Associations between patient knowledge of others' experiences and treatment choice in men with localized prostate cancer.
First Author: Aaron J. Katz
Poster
2016 Genitourinary Cancers Symposium
Pre-treatment nomogram to predict potency after treatment for localized prostate cancer.
First Author: Joseph Zabell
Poster
2015 Genitourinary Cancers Symposium
Temporal trends in the management of localized prostate cancer: From 2004 to 2011.
First Author: Phillip John Gray
Poster
2012 ASCO Quality Care Symposium
Nomogram predicting treatment-related bowel dysfunction for men with localized prostate cancer treated by radical prostatectomy (RP), external-beam radiotherapy (EBRT), and brachytherapy (PI).
First Author: Joseph Klink